Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 19574 | 435 | 43.1 | 77% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 40 | 31853 | AIDS RESEARCH AND HUMAN RETROVIRUSES//HIV 1//AIDS |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | ANTI R7V ANTIBODIES | Author keyword | 3 | 100% | 1% | 3 |
| 2 | C ADE | Author keyword | 3 | 100% | 1% | 3 |
| 3 | T CELL INFECTION | Author keyword | 2 | 67% | 0% | 2 |
| 4 | INFECTION ENHANCEMENT | Author keyword | 2 | 50% | 1% | 3 |
| 5 | LUDWIG BOLTZMANN AIDS | Address | 1 | 14% | 2% | 10 |
| 6 | LEUKOCYTE IMMUNOCHEM | Address | 1 | 31% | 1% | 4 |
| 7 | BIOCHEM ENGN ARTIFICIAL HEART | Address | 1 | 100% | 0% | 2 |
| 8 | ENHANCING ANTIBODIES | Author keyword | 1 | 100% | 0% | 2 |
| 9 | UNITE IMMUNORETROVIROL HUMAINE | Address | 1 | 50% | 0% | 2 |
| 10 | ALTERNATIVE C PATHWAY | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ANTI R7V ANTIBODIES | 3 | 100% | 1% | 3 | Search ANTI+R7V+ANTIBODIES | Search ANTI+R7V+ANTIBODIES |
| 2 | C ADE | 3 | 100% | 1% | 3 | Search C+ADE | Search C+ADE |
| 3 | T CELL INFECTION | 2 | 67% | 0% | 2 | Search T+CELL+INFECTION | Search T+CELL+INFECTION |
| 4 | INFECTION ENHANCEMENT | 2 | 50% | 1% | 3 | Search INFECTION+ENHANCEMENT | Search INFECTION+ENHANCEMENT |
| 5 | ENHANCING ANTIBODIES | 1 | 100% | 0% | 2 | Search ENHANCING+ANTIBODIES | Search ENHANCING+ANTIBODIES |
| 6 | ALTERNATIVE C PATHWAY | 1 | 50% | 0% | 1 | Search ALTERNATIVE+C+PATHWAY | Search ALTERNATIVE+C+PATHWAY |
| 7 | ANTI R7V ANTIBODY | 1 | 50% | 0% | 1 | Search ANTI+R7V+ANTIBODY | Search ANTI+R7V+ANTIBODY |
| 8 | CD4 MOLECULES | 1 | 50% | 0% | 1 | Search CD4+MOLECULES | Search CD4+MOLECULES |
| 9 | CD99 RELATED PROTEIN | 1 | 50% | 0% | 1 | Search CD99+RELATED+PROTEIN | Search CD99+RELATED+PROTEIN |
| 10 | COMPLEMENT MEDIATED PHAGOCYTOSIS | 1 | 50% | 0% | 1 | Search COMPLEMENT+MEDIATED+PHAGOCYTOSIS | Search COMPLEMENT+MEDIATED+PHAGOCYTOSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | OPSONIZED HIV | 23 | 86% | 3% | 12 |
| 2 | HOST HLA DR | 6 | 80% | 1% | 4 |
| 3 | COMPLEMENT MEDIATED ENHANCEMENT | 5 | 60% | 1% | 6 |
| 4 | ENHANCING ANTIBODIES | 5 | 36% | 3% | 12 |
| 5 | CLASS II HISTOCOMPATIBILITY | 5 | 47% | 2% | 8 |
| 6 | LYMPHOADENOPATHY SYNDROME | 5 | 63% | 1% | 5 |
| 7 | RNA TUMOR VIRUSES | 4 | 24% | 4% | 16 |
| 8 | HIV 1 PLASMA VIRUS | 4 | 75% | 1% | 3 |
| 9 | ANTIGENIC HOMOLOGY | 3 | 45% | 1% | 5 |
| 10 | CR 1 CD35 | 3 | 22% | 3% | 11 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Complement-opsonized HIV: the free rider on its way to infection | 2005 | 34 | 68 | 53% |
| Humoral immunity to HIV-1: neutralisation and antibody effector functions | 2008 | 32 | 96 | 32% |
| Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications | 2003 | 106 | 96 | 28% |
| The good and evil of complement activation in HIV-1 infection | 2010 | 10 | 140 | 28% |
| The supportive role of complement in HIV pathogenesis | 2001 | 40 | 84 | 37% |
| Antibody-mediated enhancement of viral disease | 2001 | 56 | 98 | 28% |
| Blood compatibility of enveloped viruses | 2010 | 6 | 76 | 25% |
| The relevance of complement to virus biology | 2004 | 53 | 78 | 22% |
| Characterization and role of lentivirus-associated host proteins | 2006 | 20 | 109 | 27% |
| Complement and antibodies: A dangerous liaison in HIV infection? | 2008 | 8 | 146 | 32% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | LUDWIG BOLTZMANN AIDS | 1 | 14% | 2.3% | 10 |
| 2 | LEUKOCYTE IMMUNOCHEM | 1 | 31% | 0.9% | 4 |
| 3 | BIOCHEM ENGN ARTIFICIAL HEART | 1 | 100% | 0.5% | 2 |
| 4 | UNITE IMMUNORETROVIROL HUMAINE | 1 | 50% | 0.5% | 2 |
| 5 | COMPREHENS HLTH DISPAR HIV | 1 | 50% | 0.2% | 1 |
| 6 | MANHATTAN VA MED | 1 | 50% | 0.2% | 1 |
| 7 | PHYSIOPATHOL TOULOUSE PURPAN ONCOGENESIS | 1 | 50% | 0.2% | 1 |
| 8 | UNIDAD IMMUNOPATOL | 1 | 50% | 0.2% | 1 |
| 9 | URRMA RD | 1 | 50% | 0.2% | 1 |
| 10 | VACCINE ISTANT DIS SECT | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000203034 | HIV 1 GP41//GP120 CD4 INTERACTION//CD4 RECEPTOR |
| 2 | 0.0000157928 | CD21//COMPLEMENT RECEPTOR 2//CR2 |
| 3 | 0.0000119044 | IAVI NEUTRALIZING ANTIBODY//DUKE HUMAN VACCINE//HIV AIDS VACCINE IMMUNOL IMMUNOGEN DISCOVER |
| 4 | 0.0000100434 | DC SIGN//DC SIGNR//L SIGN |
| 5 | 0.0000084861 | SIV//SHIV//SIMIAN IMMUNODEFICIENCY VIRUS |
| 6 | 0.0000084421 | VIRUS CELL INTERACT SECT//GAG//M PMV |
| 7 | 0.0000081611 | FOLLICULAR DENDRITIC CELLS//FOLLICULAR DENDRITIC CELL//RAT LYMPH NODE |
| 8 | 0.0000081029 | COMPLEMENT RECEPTOR 1//COMPLEMENT RECEPTOR TYPE 1//CR1 |
| 9 | 0.0000076854 | CD59//CRRY//CD55 |
| 10 | 0.0000072878 | SERV REG MALAD INFECT//EQUIPE INTERFERON CYTOKINES//PHARMA NEW TECHNOL |